- Home
- ZEPP vs BRNS Comparison
ZEPP vs BRNS Comparison
Compare ZEPP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- BRNS
- Stock Information
- Founded
- ZEPP 2013
- BRNS 2016
- Country
- ZEPP Netherlands
- BRNS United Kingdom
- Employees
- ZEPP N/A
- BRNS N/A
- Industry
- ZEPP Computer Manufacturing
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- BRNS Health Care
- Exchange
- ZEPP Nasdaq
- BRNS Nasdaq
- Market Cap
- ZEPP 696.3M
- BRNS 48.3M
- IPO Year
- ZEPP N/A
- BRNS 2021
- Fundamental
- Price
- ZEPP $46.47
- BRNS $1.08
- Analyst Decision
- ZEPP
- BRNS Strong Buy
- Analyst Count
- ZEPP 0
- BRNS 1
- Target Price
- ZEPP N/A
- BRNS $3.00
- AVG Volume (30 Days)
- ZEPP 462.5K
- BRNS 42.9K
- Earning Date
- ZEPP 11-17-2025
- BRNS 11-05-2025
- Dividend Yield
- ZEPP N/A
- BRNS N/A
- EPS Growth
- ZEPP N/A
- BRNS N/A
- EPS
- ZEPP N/A
- BRNS N/A
- Revenue
- ZEPP $199,947,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ZEPP $851.79
- BRNS N/A
- Revenue Next Year
- ZEPP $14.33
- BRNS N/A
- P/E Ratio
- ZEPP N/A
- BRNS N/A
- Revenue Growth
- ZEPP N/A
- BRNS 1766.46
- 52 Week Low
- ZEPP $2.13
- BRNS $0.64
- 52 Week High
- ZEPP $55.99
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- ZEPP 58.69
- BRNS 42.67
- Support Level
- ZEPP $43.31
- BRNS $0.99
- Resistance Level
- ZEPP $48.50
- BRNS $1.20
- Average True Range (ATR)
- ZEPP 5.26
- BRNS 0.08
- MACD
- ZEPP -1.31
- BRNS -0.01
- Stochastic Oscillator
- ZEPP 46.81
- BRNS 25.00
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.